Complain about a product or service

Aspirin and Colon Cancer

By Henry J. Fishman, M.D.
ConsumerAffairs.com

September 2, 2005

Colon Cancer • Chemo Benefits in Doubt for Early-Stage Colon Cancer Patients • Doctors Over-Prescribing Colonoscopies, Study Finds • Just One Colonoscopy Effective In Reducing Cancer Deaths • Colon Cancer Risk Often Has Family Links • Chemo Pump Aids in Fight Against Colon Cancer • Virtual Colonoscopy Reveals Diseases Outside Colon • Aspirin and Colon Cancer • Healthy Diet May Overcome Family Risk

Aspirin may reduce the recurrence rate and death rate for people with advanced colon cancer. This is according to researchers at the Dana Farber Cancer Institute in Boston.

Researchers studied 846 patients with Stage 3 disease that had spread outside of the colon to the lymph nodes but nowhere else. They gave half one kind of chemotherapy and half another. They interviewed the patients at 6 months and then again at 6 months after the chemotherapy ended.

Seventy-five patients took a daily dose of aspirin and 41 patients took Celebrex or some other Cox 2 inhibiter.

Regular aspirin users had a 55 percent chance of recurrence and nearly a 50 percent lower risk of death though the non aspirin users had about the same results.

Report Your Experience
If you've had a bad experience -- or a good one -- with a consumer product or service, we'd like to hear about it. All complaints are reviewed by class action attorneys and are considered for publication on our site. Knowledge is power! Help spread the word. File your consumer report now.